|
1
|
Sha N, Xie L, Chen T, Xing C, Liu X, Zhang
Y, Shen Z, Xu H, Wu Z, Hu H, et al: Impact of lymphovascular
invasion on recurrence and progression rates in patients with pT1
urothelial carcinoma of bladder after transurethral resection. Onco
Targets Ther. 8:3401–3406. 2015.PubMed/NCBI
|
|
2
|
Schlegel JU, Pipkin GE, Nishimura R and
Duke GA: Studies in the etiology and prevention of bladder
carcinoma. J Urol. 101:317–324. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caburet S, Vaiman D and Veitia RA: A
genomic basis for the evolution of vertebrate transcription factors
containing amino Acid runs. Genetics. 167:1813–1820. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen HW, Huang XD, Li HC, He S, Ni RZ,
Chen CH, Peng C, Wu G, Wang GH, Wang YY, et al: Expression of FOXJ1
in hepatocellular carcinoma: Correlation with patients' prognosis
and tumor cell proliferation. Mol Carcinog. 52:647–659. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Venugopalan SR, Amen MA, Wang J, Wong L,
Cavender AC, D'Souza RN, Akerlund M, Brody SL, Hjalt TA and Amendt
BA: Novel expression and transcriptional regulation of FoxJ1 during
oro-facial morphogenesis. Hum Mol Genet. 17:3643–3654. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Major ML, Lepe R and Costa RH: Forkhead
box M1B transcriptional activity requires binding of Cdk-cyclin
complexes for phosphorylation-dependent recruitment of p300/CBP
coactivators. Mol Cell Biol. 24:2649–2661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ono M, Yaguchi H, Ohkura N, Kitabayashi I,
Nagamura Y, Nomura T, Miyachi Y, Tsukada T and Sakaguchi S: Foxp3
controls regulatory T-cell function by interacting with AML1/Runx1.
Nature. 446:685–689. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma RY, Tong TH, Leung WY and Yao KM:
Raf/MEK/MAPK signaling stimulates the nuclear translocation and
transactivating activity of FOXM1. Methods Mol Biol. 647:113–123.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Postnikoff SD, Malo ME, Wong B and
Harkness TA: The yeast forkhead transcription factors fkh1 and fkh2
regulate lifespan and stress response together with the
anaphase-promoting complex. PLoS Genet. 8:e10025832012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Laoukili J, Kooistra MR, Brás A, Kauw J,
Kerkhoven RM, Morrison A, Clevers H and Medema RH: FoxM1 is
required for execution of the mitotic programme and chromosome
stability. Nat Cell Biol. 7:126–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karadedou CT, Gomes AR, Chen J, Petkovic
M, Ho KK, Zwolinska AK, Feltes A, Wong SY, Chan KY, Cheung YN, et
al: FOXO3a represses VEGF expression through FOXM1-dependent and
-independent mechanisms in breast cancer. Oncogene. 31:1845–1858.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin L, Spoor MS, Gerth AJ, Brody SL and
Peng SL: Modulation of Th1 activation and inflammation by the
NF-kappaB repressor Foxj1. Science. 303:1017–1020. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Demircan B, Dyer LM, Gerace M, Lobenhofer
EK, Robertson KD and Brown KD: Comparative epigenomics of human and
mouse mammary tumors. Genes Chromosomes Cancer. 48:83–97. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu T and Stark GR: Cytokine overexpression
and constitutive NFkappaB in cancer. Cell Cycle. 3:1114–1117. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siu MK, Wong ES, Kong DS, Chan HY, Jiang
L, Wong OG, Lam EW, Chan KK, Ngan HY, Le XF, et al: Stem cell
transcription factor NANOG controls cell migration and invasion via
dysregulation of E-cadherin and FoxJ1 and contributes to adverse
clinical outcome in ovarian cancers. Oncogene. 32:3500–3509. 2013.
View Article : Google Scholar : PubMed/NCBI
|
